Deciphering the molecular basis of invasiveness in Sdhb-deficient cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1485 views | HTML 3072 views | ?
Céline Loriot1,2, Mélanie Domingues2,3, Adeline Berger4,5, Mélanie Menara1,2, Maëva Ruel1,2, Aurélie Morin1,2, Luis-Jaime Castro-Vega1,2, Éric Letouzé6, Cosimo Martinelli1,2, Alexis-Pierre Bemelmans7,8, Lionel Larue3, Anne-Paule Gimenez-Roqueplo1,2,9,10, Judith Favier1,2
1INSERM, UMR970, Paris Cardiovascular Research Centre, F-75015 Paris, France
2Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, F-75006 Paris, France
3INSERM, U1021, CNRS UMR3347, Institut Curie, F-91405 Orsay, France
4INSERM, U968, Institut de la vision, F-75012 Paris, France
5Université Pierre et Marie Curie Paris 06, F-75005 Paris, France
6Programme Cartes d’Identité des Tumeurs, Ligue Nationale Contre Le Cancer, F-75013 Paris, France
7CEA, DSV, I2BM, Molecular Imaging Research Center (MIRCen), F-92265 Fontenay-aux-Roses, France
8CNRS, CEA URA 2210, F-92265 Fontenay-aux-Roses, France
9Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique, F-75015 Paris, France
10Rare Adrenal Cancer Network-Cortico Médullosurrénale Tumeurs Endocrines, Institut National du Cancer, F-75014 Paris, France
Judith Favier, e-mail: [email protected]
Keywords: paraganglioma, SDHB, metastasis, EMT, keratin 19
Received: May 11, 2015 Accepted: September 25, 2015 Published: October 08, 2015
Metastatic pheochromocytomas and paragangliomas (PPGL) are malignant neuroendocrine tumors frequently associated with germline mutations in the SDHB gene. SDHB-mutated PPGL display a hypermethylator phenotype associated with hallmarks of epithelial-to-mesenchymal transition (EMT). In the present study, we report the characterization of a unique model of Sdhb knockout in mouse chromaffin cells. Sdhb deficient cells exhibit a metastatic phenotype as highlighted by increased individual cell migration (characterized by faster motility and increased persistence) as well as high invasive and adhesion abilities. This phenotype is associated with the modulation of Twist1, Twist2, Tcf3, Snai1, N-cadherin or Krt19 expression, reflecting an EMT-like reprogramming of cells. Krt19 is epigenetically silenced in Sdhb-deficient cells and re-expressed after treatment by the demethylating agent decitabine. Krt19 rescue by lentiviral transduction in Sdhb-deficient cells and Krt19 inhibition by RNA interference in wild-type cells were performed. Both studies revealed the involvement of KRT19 in the invasive phenotype by modulating collective and individual migration and cell/extra-cellular matrix adhesion properties. These findings underline the role of hypermethylation and EMT in the in vitro acquisition of metastatic properties, following SDHB loss of function.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.